255 related articles for article (PubMed ID: 26351809)
1. Novel drug targets in acute leukemia.
Stock W
Clin Adv Hematol Oncol; 2015 Aug; 13(8):493-5. PubMed ID: 26351809
[No Abstract] [Full Text] [Related]
2. Emerging therapeutic targets in human acute myeloid leukemia (part 2) - bromodomain inhibition should be considered as a possible strategy for various patient subsets.
Reikvam H; Hoang TT; Bruserud Ø
Expert Rev Hematol; 2015 Jun; 8(3):315-27. PubMed ID: 25901742
[TBL] [Abstract][Full Text] [Related]
3. Drug development: target practice.
Katsnelson A
Nature; 2013 Jun; 498(7455):S8-9. PubMed ID: 23803950
[No Abstract] [Full Text] [Related]
4. Stem cell transplantation in acute leukemia.
Gorin NC
Ann N Y Acad Sci; 1995 Dec; 770():262-87. PubMed ID: 8597366
[No Abstract] [Full Text] [Related]
5. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
6. Reasons for optimism in the therapy of acute leukemia.
Rowe JM
Best Pract Res Clin Haematol; 2015; 28(2-3):69-72. PubMed ID: 26590761
[TBL] [Abstract][Full Text] [Related]
7. Adult ALL: where are we and where are we going?
Larson RA
Clin Adv Hematol Oncol; 2004 Jun; 2(6):342-4. PubMed ID: 16163203
[No Abstract] [Full Text] [Related]
8. Recent advances in the understanding and treatment of pediatric leukemias.
Maloney KW; Giller R; Hunger SP
Adv Pediatr; 2012; 59(1):329-58. PubMed ID: 22789585
[No Abstract] [Full Text] [Related]
9. Current and future management of Ph/BCR-ABL positive ALL.
Maino E; Sancetta R; Viero P; Imbergamo S; Scattolin AM; Vespignani M; Bassan R
Expert Rev Anticancer Ther; 2014 Jun; 14(6):723-40. PubMed ID: 24611626
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.
Tischer J; Stemmler HJ; Engel N; Hubmann M; Fritsch S; Prevalsek D; Schulz C; Zoellner AK; Bücklein V; Hill W; Ledderose G; Hausmann A
Ann Hematol; 2013 Oct; 92(10):1379-88. PubMed ID: 23928857
[TBL] [Abstract][Full Text] [Related]
11. Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
Shaw BE; Russell NH
Bone Marrow Transplant; 2008 Mar; 41(5):495-503. PubMed ID: 17952130
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
Brennan L; Narendran A
Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
[TBL] [Abstract][Full Text] [Related]
13. Consistent genetic abnormalities in human cancers as targets for selective therapies.
Clarkson BD
Mt Sinai J Med; 1992 Oct; 59(5):400-4. PubMed ID: 1435835
[No Abstract] [Full Text] [Related]
14. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia.
Wang L; Liu DH
Chin Med J (Engl); 2017 Jan; 130(2):127-129. PubMed ID: 28091401
[No Abstract] [Full Text] [Related]
16. Emerging therapeutic targets for the treatment of human acute myeloid leukemia (part 1) - gene transcription, cell cycle regulation, metabolism and intercellular communication.
Reikvam H; Hauge M; Brenner AK; Hatfield KJ; Bruserud Ø
Expert Rev Hematol; 2015 Jun; 8(3):299-313. PubMed ID: 25835070
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia.
Leoni V; Biondi A
Haematologica; 2015 Mar; 100(3):295-9. PubMed ID: 25740105
[No Abstract] [Full Text] [Related]
18. New Models of Therapy: When Acute Leukemia Becomes Chronic.
Ustun C; Stone R; Weisdorf D
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1856-7. PubMed ID: 26183079
[No Abstract] [Full Text] [Related]
19. Future of Therapy in Acute Lymphoblastic Leukemia (ALL)--Potential Role of Immune-Based Therapies.
Kebriaei P; Poon ML
Curr Hematol Malig Rep; 2015 Jun; 10(2):76-85. PubMed ID: 25899862
[TBL] [Abstract][Full Text] [Related]
20. Novel therapeutics in acute myeloid leukemia.
Sweet K; Lancet JE
Curr Hematol Malig Rep; 2014 Jun; 9(2):109-17. PubMed ID: 24633743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
